CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-01 | Biller Scott Chief Scientific Officer | Sale | −900 | $63.09 | $57K | 7,210 |
| 2017-11-01 | Biller Scott Chief Scientific Officer | Sale | −946 | $61.81 | $58K | 6,264 |
| 2017-11-01 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,146 | 32,185 | ||
| 2017-11-01 | Schenkein David P Chief Executive Officer | Option exercise | +6,000 | $0.30 | $2K | 6,000 |
| 2017-11-01 | Schenkein David P Chief Executive Officer | Sale | −200 | $66.75 | $13K | 5,800 |
| 2017-11-01 | Schenkein David P Chief Executive Officer | Sale | −598 | $65.42 | $39K | 5,202 |
| 2017-11-01 | Schenkein David P Chief Executive Officer | Sale | −942 | $64.64 | $61K | 4,260 |
| 2017-11-01 | Schenkein David P Chief Executive Officer | Sale | −4,260 | $63.32 | $270K | 0 |
| 2017-11-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −6,000 | 26,656 | ||
| 2017-10-17 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $71.10 | $71K | 83,394 |
| 2017-10-17 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $71.10 | $71K | 83,434 |
| 2017-10-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $71.09 | $71K | 84,394 |
| 2017-10-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $71.09 | $71K | 84,434 |
| 2017-10-04 | Biller Scott Chief Scientific Officer | Sale | −10,470 | $70.00 | $733K | 0 |
| 2017-10-04 | Schenkein David P Chief Executive Officer | Option exercise | +80,000 | $0.30 | $24K | 80,000 |
| 2017-10-04 | Schenkein David P Chief Executive Officer | Sale | −80,000 | $70.14 | $5.6M | 0 |
| 2017-10-04 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −80,000 | 32,656 | ||
| 2017-10-02 | Biller Scott Chief Scientific Officer | Option exercise | +1,191 | $9.05 | $11K | 7,455 |
| 2017-10-02 | Biller Scott Chief Scientific Officer | Sale | −1,191 | $67.23 | $80K | 6,264 |
| 2017-10-02 | Biller Scott Chief Scientific Officer | Option exercise | +955 | $31.64 | $30K | 7,219 |
Page 71 of 80 · 1,590 trades